Nafenodone

This classification denotes an antidepressant agent with the molecular formula C20H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0O501R1CSQ, chemically known as 1(2h)-naphthalenone, 3,4-dihydro-2-(2-(dimethylamino)ethyl)-2-phenyl-, (s)- but generally known as nafenodone, which bears US NIH Compound Identifier 65834. European Medicines Agency schedules Nafenodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09119MIG. The term NAFENODONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). NAFENODONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nafenodone under HS 29223900 and SITC 51463. As of Q4 2014, NAFENODONE remains the US FDA Preferred Term for this commodity. Nafenodone bears US NLM identifiers UMLS ID C0131796 and NCI Concept Code C72821. SMILES: O=C1C(CCc2c1cccc2)(CCN(C)C)c1ccccc1.